StonvexLoading…
StonvexStonvexStonvexCore line items from CRK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.22B | $1.25B | $1.57B | $3.63B |
Operating Income | $645.85M | $-168.62M | $226.60M | $2.28B |
Net Income | $395.61M | $-229.65M | $211.12M | $1.12B |
EPS (Diluted) | $1.43 | $-0.76 | $0.76 | $4.11 |
Total Assets | $7.01B | $6.38B | $6.25B | $5.69B |
Total Liabilities | $4.04B | $4.05B | $3.87B | $3.42B |
Cash & Equivalents | $23.93M | $6.80M | $16.67M | $54.65M |
Free Cash Flow OCF − CapEx | $-449.67M | $-477.14M | $-408.24M | $630.59M |
Shares Outstanding | 293.05M | 292.26M | 278.43M | 277.52M |